Highlights From EASL 2014

Gastroenterology & Hepatology May 2014, Volume 10, Issue 5 By Dee Rapposelli Fixed-Dose Sofosbuvir/Ledipasvir Potent in Treatment-Experienced Patients with Genotype 1 HCV Infection Twelve-week sustained viral response (SVR) rates […]

Highlights From The Annual Meeting Of The AASLD

Gastroenterology & Hepatology March 2014, Volume 10, Issue 3 By Dee Rapposelli Addition of Rifaximin Shows Value in Intercepting Complications of Cirrhosis Complications are more […]